Books in the CABI Biotechnology Series series

Transgenic plants are cultivated globally on a large scale, and mostly fed to domestic animals. Including over 150 feeding studies with food-producing animals, and covering first and second generation transgenic plants, this book is the first key resource of this information for researchers, students and policy makers.

This book adopts a methodical approach to provide a novel exploration of the effects of GM crops on global economy, as well as examining the links between GM and food security at global and regional levels. The environmental implications of GM are also considered, by comparing pesticide use and efficiency in GM and non-GM countries.

An authoritative update of forest tree biotechnology and genomics methodologies, this book discusses approaches for traditional breeding improvement of forest-tree species and production of forest-based products. It describes in detail the environmental, social, legal, and regulatory aspects of forest biotechnology, with an emphasis on biosafety.

This book describes the use of Bt crops and the emerging problem of resistance. Covering recent progress in understanding the mechanism of action of Bt toxins, different resistance mechanisms and strategies to cope with resistance in the field, it reviews successes and failures from around the world.

Plant gene silencing through RNA interference can be used to improve industrial traits, adding nutritional benefits, removing allergens and other valuable factors for consumers, and to protect plants against bacterial and viral pathogens, weeds and pests. This is the first book to combine the biological phenomenon and the practical applications.

Insect transgenesis promises improvements in agriculture, pharmaceuticals and public health. This book discusses the latest insect transgenesis technology and its applications. It considers the larger risks, social and economic aspects of transgenic insects whose value must be proven in political, regulatory and public acceptance arenas.

Describing developments in the engineering and generation of plants as production platforms for biopharmaceuticals, this book includes vaccines and monoclonal antibodies. It discusses targeting diseases which predominate in less developed countries, encompassing the current state of technologies and describing expression systems and applications.